Cell-surface expression and immune receptor recognition of HLA-B27 homodimers

Arthritis and Rheumatism

Volumn 46, Issue 11, 2002, Pages 2972-2982

  Kollnberger, Simon ^a   Bird, Lucy ^a   Sun, Mei Yi ^a   Retiere, Christelle ^a   Braud, Veronique M ^b   McMichael, Andrew ^a   Bowness, Paul ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CELL ANTIGEN; CELL RECEPTOR; CELL SURFACE PROTEIN; DIMER; HISTAMINE; HLA B27 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN LIKE TRANSCRIPT 2; IMMUNOGLOBULIN LIKE TRANSCRIPT 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HC10; PROTEIN KIR3DL1; PROTEIN KIR3DL2; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; BLOOD; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HUMAN; MALE; MONOCYTE; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; SPONDYLARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE; WESTERN BLOTTING;

ADULT; ANTIGENS, SURFACE; DIMERIZATION; FEMALE; HLA-B27 ANTIGEN; HUMANS; LYMPHOCYTES; MALE; MONOCYTES; RECEPTORS, IMMUNOLOGIC; SPONDYLARTHRITIS; SYNOVIAL FLUID; T-LYMPHOCYTES;

EID: 0036846149     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10605     Document Type: Article

References (36)

1. Allen RL, Bowness P, McMichael A. The role of HLA-B27 in spondyloarthritis. Immunogenetics 1999;50:220-7.
2. 2m: An animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-112.
3. 2-microglobulin: A model of human spondyloarthropathies. J Exp Med 1995;182:1153-8.
4. 2m. J Clin Invest 1996;98:2746-55.
5. Khare SD, Bull MJ, Hanson J, Luthra HS, David CS. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: A direct role for B27 heavy chains and not B27-derived peptides. J Immunol 1998;160:101-6.
6. Stam NJ, Spits H, Ploegh HL. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 1986;137:2299-306.
7. Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 1993;150:4168-78.
8. Breban M, Fernandez-Sueiro JL, Richardson JA, Hadavand RR, Maika SD, Hammer RE, et al. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 1996;156:794-803.
9. 2-microglobulin-free heavy chain homodimer structure. J Immunol 1999;162:5045-8.
10. Andre P, Biassoni R, Colonna M, Cosman D, Lanier LL, Long EO, et al. New nomenclature for MHC receptors. Nat Immunol 2001;2:661.
11. Lanier LL. Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 1998;92:705-7.
12. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997;186:1809-18.
13. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998;160:3096-100.
14. Allan DS, Colonna M, Lanier LL, Churakova TD, Abrams JS, Ellis SA, et al. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med 1999;189:1149-56.
15. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
16. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A1,2. J Immunol 1996;156:3098-101.
17. Peruzzi M, Wagtmann N, Long EO. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J Exp Med 1996;184:1585-90.
18. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, di Donato C, et al. The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996;184:505-18.
19. 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 1990;344:742-6.
20. 2-microglobulin. J Exp Med 1990;171:1431-42.
21. Matko J, Bushkin Y, Wei T, Edidin M. Clustering of class I HLA molecules on the surfaces of activated and transformed human cells. J Immunol 1994;152:3353-60.
22. Allen RL, Raine T, Haude A, Trowsdale J, Wilson MJ. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol 2001;167:5543-7.
23. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994;180:1235-42.
24. Spencer JV, Braciale TJ. Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen. J Exp Med 2000;191:1687-98.
25. Drake DR III, Braciale TJ. Cutting edge: Lipid raft integrity affects the efficiency of MHC class I tetramer binding and cell surface TCR arrangement on CD8+ T cells. J Immunol 2001;166:7009-13.
26. Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, Rajalingam R, et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 2001;166:2992-3001.
27. Young NT, Uhrberg M, Phillips JH, Lanier LL, Parham P. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol 2001;166:3933-41.
28. Ugolini S, Arpin C, Anfossi N, Walzer T, Cambiaggi A, Forster R, et al. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Nat Immunol 2001;2:430-5.
29. Borges L, Hsu ML, Fanger N, Kubin M, Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 1997;159:5192-6.
30. Chapman TL, Heikema AP, Bjorkman PJ. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 1999;11:603-13.
31. Chapman TL, Heikema AP, West AP Jr, Bjorkman PJ. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 2000;13:727-36.
32. Marietta E, Trejo T, Luthra H, David C. The role of natural killer (NK) cells on HLA-B27 associated arthritis [abstract]. Arthritis Rheum 2000;43 Suppl 9:S263.
33. Kubagawa H, Burrows PD, Cooper MD. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci U S A 1997;94:5261-6.
34. Dennis G Jr, Stephan RP, Kubagawa H, Cooper MD. Characterization of paired Ig-like receptors in rats. J Immunol 1999;163:6371-7.
35. 2-microglobulin-deficient mice without expression of HLA-B27: Association with deficiency of endogenous major histocompatibility complex class I expression. Arthritis Rheum 2000;43:2290-6.
36. Taurog JD, Maika SD, Satumtira N, Dorris ML, McLean IL, Yanagisawa H, et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999;169:209-23.